Skip to content
Research Article Open access CC BY 4.0

Resveratrol Reduces C-reactive Protein and Cholesterol in Schizophrenia

Karine Zortea, Viviane Carvalho Franco, Lenise Petter Francesconi, Paulo Belmonte-de-Abreu

International Neuropsychiatric Disease Journal · pp. 1–4 · Published 19 Oct 2015

10.9734/INDJ/2016/22181

Abstract

Patients with schizophrenia (SZ) are generally found with overweight and obesity and several metabolic disorders. Additionally these patients have less life expectancy, with cardiovascular disease (CVD) the main cause of increased mortality in these patients. This is a case-report study of a male, 46 years old, with Diagnosis of SZ following a 1-month resveratrol supplementation program. In summary, we observed association of resveratrol supplementation (200 mg/day) with reduced C-reactive protein (CRP), and reduced cholesterol and triglycerides. The benefits included the improvement in Framingham score and mean reduction of 3% of risk of a heart attack over the next 10 years.   

Schizophrenia Cardiovascular Diseases Inflammation Resveratrol

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.